Report of a workshop on malignant lymphoma: a review of molecular and clinical risk profiling-Reference-Cited by-同舟云学术

Report of a workshop on malignant lymphoma: a review of molecular and clinical risk profiling

Published:2008-07 Issue:2 Volume:142 Page:166-178
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:

Author:

Gleissner B.,Kppers R.,Siebert R.,Glass B.,Trmper L.,Hiddemann W.,Dreyling M.

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2141.2008.07138.x/fullpdf

Reference93 articles.

1. A phase I study of humanized anti-CD40 immunotherapy with SGN-40 in non-Hodgkins lymphoma;Advani;Blood,2005

2. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling;Alizadeh;Nature,2000

3. The presence of STAT1-positive tumor-associated macrophages and their relation to outcome in patients with follicular lymphoma;Alvaro;Haematologica,2006

4. Diffuse large B-cell lymphoma subgroups have distinct genetic profiles that influence tumor biology and improve gene-expression-based survival prediction;Bea;Blood,2005

5. A phase II study of bortezomib in mantle cell lymphoma: the National Cancer Institute of Canada Clinical Trials Group trial IND.150;Belch;Annals of Oncology,2007

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. High-Risk Pregnancy;2017-11-15

2. Lymphoid Leukaemias of Mature B, T and Natural Killer Cells;Leukaemia Diagnosis;2017-03-25

3. Laboratory Diagnosis of Haematological Neoplasms;Postgraduate Haematology;2015-11-06

4. PARP1 expression in mantle cell lymphoma: the utility of PARP1 immunohistochemistry and its relationship with markers of DNA damage;Hematological Oncology;2014-08-20

5. Prolonged progression-free survival and preserved quality of life in the Canadian prospective study of tositumomab and iodine131-tositumomab for previously treated, rituximab-exposed, indolent non-Hodgkin lymphoma;Leukemia & Lymphoma;2014-04-03